CLINICAL_TRIALS
withdrawal
· 2015-09-01
Clinical Trial Update: A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) [NA]
Summary
Clinical trial update indicates that a prospective open-label dose-ranging study of pre-TURBT intravesical mitomycin C mixed with TC-3 Gel for non-muscle invasi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UroGen Pharma Ltd. | Conditions: Non Muscle Invasive Bladder Cancer | NA | Status: WITHDRAWN